THE Board of the Generic and Biosimilar Medicines Association (GBMA) has announced its Chief Executive Officer of seven years, Marnie Peterson, will complete her tenure at the end of 2025.
The GBMA Board and members thanked Peterson for her outstanding leadership, strategic foresight and unwavering commitment to improving access to affordable medicines for all Australians.
The Independent Chair of the GBMA, Professor Jane Halton, praised Peterson for her leadership through some of the organisation's most challenging and transformative years, including managing global supply chain disruptions during the pandemic.
Peterson will remain in her role as CEO until the end of Dec, with plans for succession to be decided in due course.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Jul 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Jul 25
